Positive Outlook for Carl Zeiss Meditec
"The entire Supervisory Board is impressed by the results achieved. With a targeted strategic direction, it has proved possible under Dr. Kaschke's leadership to keep the company on a path of success and growth even in these difficult economic times. For that reason, we will continue to put our trust in continuity," explained Dr. Markus Guthoff, Chairman of the Supervisory Board of Carl Zeiss Meditec AG.
"With a targeted focus on innovation, customer orientation and growth markets, we are posting pleasing results even in the context of the current economic situation. We will continue to invest in future-oriented topics. We can confirm our statement that Carl Zeiss Meditec will continue to grow while keeping the profitability stable and increasing it in the medium term. Compared to last year, we anticipate revenue growth of at least 5 percent in this current adverse year," concluded Dr. Michael Kaschke, President and CEO of Carl Zeiss Meditec AG.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.